| scholarly article | Q13442814 |
| P2093 | author name string | Daniela Taverna | |
| Francesca Orso | |||
| Thaiz F Borin | |||
| Debora A P C Zuccari | |||
| Lívia C Ferreira | |||
| Daniela Dettori | |||
| Jéssica Z Lacerda | |||
| P2860 | cites work | Neurotoxins: free radical mechanisms and melatonin protection | Q22305781 |
| Melatonin Represses Metastasis in Her2-Postive Human Breast Cancer Cells by Suppressing RSK2 Expression | Q38734026 | ||
| Melatonin and the von Hippel-Lindau/HIF-1 oxygen sensing mechanism: A review | Q38743052 | ||
| Melatonin Regulates Angiogenic and Inflammatory Proteins in MDA-MB-231 Cell Line and in Co-culture with Cancer-associated Fibroblasts. | Q38776358 | ||
| Melatonin uptake through glucose transporters: a new target for melatonin inhibition of cancer | Q38917542 | ||
| miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2. | Q39028436 | ||
| Melatonin suppresses tumor progression by reducing angiogenesis stimulated by HIF-1 in a mouse tumor model | Q39290492 | ||
| In vitro and in vivo antitumor activity of melatonin receptor agonists | Q39683381 | ||
| Molecular mechanisms of melatonin anticancer effects | Q39755885 | ||
| Melatonin-induced KiSS1 expression inhibits triple-negative breast cancer cell invasiveness | Q41145166 | ||
| Melatonin protects the mitochondria from oxidative damage reducing oxygen consumption, membrane potential, and superoxide anion production | Q46215618 | ||
| Declining melatonin levels and MT1 receptor expression in aging rats is associated with enhanced mammary tumor growth and decreased sensitivity to melatonin | Q48165379 | ||
| Melatonin Regulates Angiogenic Factors under Hypoxia in Breast Cancer Cell Lines. | Q51632261 | ||
| International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors | Q24623433 | ||
| miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer | Q24630894 | ||
| miR-214 as a key hub that controls cancer networks: small player, multiple functions | Q27023833 | ||
| Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats | Q28284736 | ||
| miRNAs, cancer, and stem cell division | Q29618925 | ||
| Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis | Q33624824 | ||
| Melatonin modulation of crosstalk among malignant epithelial, endothelial and adipose cells in breast cancer (Review). | Q33844198 | ||
| Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status | Q34625392 | ||
| Melatonin anticancer effects: review | Q34647628 | ||
| Upregulation of miRNA3195 and miRNA374b Mediates the Anti-Angiogenic Properties of Melatonin in Hypoxic PC-3 Prostate Cancer Cells | Q34784899 | ||
| miR-150-5p inhibits hepatoma cell migration and invasion by targeting MMP14. | Q34790217 | ||
| microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C. | Q34993968 | ||
| MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT. | Q34995499 | ||
| MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/β-catenin pathway | Q35025308 | ||
| miR-214 and miR-148b Targeting Inhibits Dissemination of Melanoma and Breast Cancer. | Q36058142 | ||
| The microRNA-148/152 family: multi-faceted players | Q36898251 | ||
| Breast cancer as a systemic disease: a view of metastasis | Q37011741 | ||
| Multitargeting activity of miR-24 inhibits long-term melatonin anticancer effects | Q37190361 | ||
| Melatonin decreases breast cancer metastasis by modulating Rho-associated kinase protein-1 expression. | Q37200722 | ||
| MicroRNA-210 interacts with FBXO31 to regulate cancer proliferation cell cycle and migration in human breast cancer | Q37213238 | ||
| Melatonin signaling and cell protection function | Q37763812 | ||
| Metastasis-related miRNAs, active players in breast cancer invasion, and metastasis | Q37799571 | ||
| Basic Mechanisms Involved in the Anti-Cancer Effects of Melatonin | Q37808250 | ||
| Breast cancer therapy based on melatonin. | Q37988609 | ||
| Therapeutic application of MicroRNAs against human cancers. | Q38028438 | ||
| Molecular mechanisms of melatonin's inhibitory actions on breast cancers. | Q38046127 | ||
| The role of microRNA in resistance to breast cancer therapy | Q38231981 | ||
| MicroRNA and cancer--a brief overview | Q38258057 | ||
| In vitro microenvironments to study breast cancer bone colonisation. | Q38276860 | ||
| A summary for molecular regulations of miRNAs in breast cancer | Q38300793 | ||
| Differential regulation of estrogen receptor alpha, glucocorticoid receptor and retinoic acid receptor alpha transcriptional activity by melatonin is mediated via different G proteins | Q38328378 | ||
| The role of hypoxia-induced miR-210 in cancer progression | Q38391282 | ||
| MicroRNA and gene expression analysis of melatonin-exposed human breast cancer cell lines indicating involvement of the anticancer effect | Q38502155 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P921 | main subject | triple-negative breast cancer | Q7843332 |
| P304 | page(s) | e0228062 | |
| P577 | publication date | 2020-02-03 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | The role of melatonin on miRNAs modulation in triple-negative breast cancer cells | |
| P478 | volume | 15 |
Search more.